News

GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt
The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work ...
Latest on plans to expand Cambridge Biomedical Campus with offices and conference centre
AstraZeneca has briefed councillors on their plans to build a new office and conference centre at the Cambridge Biomedical ...
Lymphoma Treatment Market to Surpass USD 14.66 Billion by 2032, Fueled by Immunotherapy Advancements and Emerging Market Expansion - SNS Insider
U.S. Market Leads with 74% Share in 2023 Valued at USD 2.71 Billion, Driven by Biotech Innovation, Favorable FDA Approvals, and Rising Chronic Disease Incidence.Austin, July 18, 2025 (GLOBE NEWSWIRE) ...
Cardiac Amyloidosis Market Research Report 2025-2035 Advancements In Targeted Therapies And Improved Access Fuel Steady Growth
The global cardiac amyloidosis market is poised for substantial growth, driven by rising prevalence and awareness of amyloidosis-related cardiac cond ...